Tumor cell proliferation in prostate cancer after 3 months of neoadjuvant LHRH analogue treatment is a prognostic marker of recurrence after radical prostatectomy-Reference-Cited by-同舟云学术

Tumor cell proliferation in prostate cancer after 3 months of neoadjuvant LHRH analogue treatment is a prognostic marker of recurrence after radical prostatectomy

Published:1999-08 Issue:2 Volume:54 Page:329-334
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Ahlgren G,Pedersen K,Lundberg S,Aus G,Hugosson J,Abrahamsson P.-A

Publisher

Elsevier BV

Subject

Urology

Reference19 articles.

1. Studies of prostatic cancer;Huggin;Cancer Res,1941

2. The influence of hormonal therapy on survival of men with advanced prostate cancer;Lepor;J Urol,1982

3. Prostate-specific antigen after anatomic radical retropubic prostatectomy;Pound;Urol Clin North Am,1997

4. Positive margins after radical prostatectomy;van den Ouden;Br J Urol,1992

5. Prognostic significance of positive surgical margins in radical prostatectomy specimens;Ohori;J Urol,1995

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Delayed Radical Prostatectomy and Active Surveillance on Localised Prostate Cancer—A Systematic Review and Meta-Analysis;Cancers;2021-06-30

2. Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review;Minerva Urologica e Nefrologica;2018-07

3. The clinicopathological significance of Ki67 in papillary thyroid carcinoma: a suitable indicator?;World Journal of Surgical Oncology;2018-05-31

4. Histone H1 expression in human prostate cancer tissues and cell lines;Pathology International;2011-11-28

5. The role of magnetic resonance imaging (MRI) in prostate cancer imaging and staging at 1.5 and 3 Tesla: The Beth Israel Deaconess Medical Center (BIDMC) approach;Cancer Biomarkers;2008-11-04